895P - SPAZO2 (SOGUG): Validation of the international metastatic database consortium (IMDC) prognostic classification for targeted therapies as 2nd-line after 1st-line pazopanib (1stPz) in metastatic renal cell carcinoma (mRC)
| Autor: | Pérez-Valderrama, B., Arranz Arija, J., Chirivella González, I., Anido Herranz, U., Jurado García, J.M., Suarez Rodriguez, C., García Carbonero, I., de Velasco, G., García Domínguez, R., García Marrero, R.D., Gonzalez Del Alba Baamonde, M.A., Molins Palau, C., Lazaro, M.E., Munoz-Langa, J., Martinez Ortega, E., Hernández Jorge, A., Campayo Guillaumes, M., Sereno Moyano, M., Luque Caro, R., Rodríguez Sánchez, Á. |
|---|---|
| Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v317-v317 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|